[HTML][HTML] Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
…, MC Becerra, A Benedetti, M Burgos, R Centis… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
…, J Cardoso-Landivar, R Centis… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …
pandemic has attracted interest because of its global rapid spread, clinical severity, high …
Towards tuberculosis elimination: an action framework for low-incidence countries
…, J Bruchfeld, F Castelli, R Centis… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …
(<100 TB cases per million population) that are striving for TB elimination. The framework …
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
…, JCM Brust, Y Cai, E Caumes, JP Cegielski, R Centis… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …
to estimate the association of treatment success and death with the use of individual drugs, …
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
…, S Keshavjee, K DeRiemer, R Centis… - European …, 2013 - Eur Respiratory Soc
A meta-analysis for response to treatment was undertaken using individual data of multidrug-resistant
tuberculosis (MDR-TB) (resistance to isoniazid and rifampicin) patients from 26 …
tuberculosis (MDR-TB) (resistance to isoniazid and rifampicin) patients from 26 …
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
G Sotgiu, R Centis, L D'Ambrosio… - European …, 2012 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study
…, RR Leyet, L D'Ambrosio, R Centis… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
[HTML][HTML] Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts
I Motta, R Centis, L D'Ambrosio, JM García-García… - Pulmonology, 2020 - Elsevier
Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim
of this study is to describe a group of patients who died with TB (active disease or sequelae) …
of this study is to describe a group of patients who died with TB (active disease or sequelae) …
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
…, M Zignol, K Floyd, R Centis… - European …, 2013 - Eur Respiratory Soc
If tuberculosis (TB) is to be eliminated as a global health problem in the foreseeable future,
improved detection of patients, earlier diagnosis and timely identification of rifampicin …
improved detection of patients, earlier diagnosis and timely identification of rifampicin …
[HTML][HTML] Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020
…, M Calnan, PF Castellotti, R Centis… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in 16
countries on 5 continents showed that attendance at tuberculosis centers was lower during …
countries on 5 continents showed that attendance at tuberculosis centers was lower during …